CVS Health Corp. (CVS)

54.94
1.10 2.00
NYSE : Retail Trade
Prev Close 56.04
Open 55.80
Day Low/High 54.40 / 56.13
52 Wk Low/High 58.46 / 82.15
Volume 12.79M
Avg Volume 12.89M
Exchange NYSE
Shares Outstanding 1.30B
Market Cap 74.45B
EPS -0.60
P/E Ratio N/A
Div & Yield 2.00 (3.56%)

Weekly Roundup

Stocks finish week sharply lower on worries over global economic growth slowing after earlier surging on Fed's more accommodating stance.

Stocks We Are Looking at During Friday's Selloff

We provide several investment ideas for those that have kept their powder dry.

Lifshitz & Miller LLP Announces Investigation Of Amarin Corporation Plc, Clementia Pharmaceuticals Inc., CVS Health Corporation, Diplomat Pharmacy, Inc., GTx, Inc., Multi-Color Corporation, Osiris Therapeutics, Inc., And The Kraft Heinz Company

Lifshitz & Miller LLP Announces Investigation Of Amarin Corporation Plc, Clementia Pharmaceuticals Inc., CVS Health Corporation, Diplomat Pharmacy, Inc., GTx, Inc., Multi-Color Corporation, Osiris Therapeutics, Inc., And The Kraft Heinz Company

NEW YORK, March 22, 2019 /PRNewswire/ -- Amarin Corporation plc (AMRN) Lifshitz & Miller announces investigation into possible securities laws violations in connection with allegations that Amarin administered an active agent to their placebo group during...

Video: Jim's Daily Rundown for Friday

Jim discusses Alphabet's stadia gaming initiative, our annual contribution to charity, the importance of individual stocks, when to buy our semiconductor stocks, and much more!

Markets Open Lower Friday, a Check on CVS Health After Last Night's Interview

We are encouraged with CVS Health's plans to fix what has hurt the company and we reiterate that the stock is still inexpensive.

Gold Stocks Are Positive on a Negative Day: Here Are My 2 Favorites

Gold Stocks Are Positive on a Negative Day: Here Are My 2 Favorites

While today's action isn't attractive, we were ripe for a little profit-taking.

Playbook for the Fed: Cramer's 'Mad Money' Recap (Thursday 3/21/19)

Playbook for the Fed: Cramer's 'Mad Money' Recap (Thursday 3/21/19)

Jim Cramer has a playbook for finding the stocks that can make money without the economy filling the sails.

Aetna Offers Assistance To Members Affected By Flooding In The Midwest

Aetna Offers Assistance To Members Affected By Flooding In The Midwest

HARTFORD, Conn., March 21, 2019 /PRNewswire/ -- Aetna, a CVS Health (NYSE:CVS) business, is offering resources to members who have been affected by floods in Illinois, Iowa, Kansas, Michigan, Nebraska, Ohio, South Dakota and Wisconsin.

Curaleaf Says Hemp Products to Be Sold at CVS Stores

Curaleaf Says Hemp Products to Be Sold at CVS Stores

Curaleaf says it signed a deal with CVS to begin selling hemp products at 800 stores in 10 states.

CVS or Walgreens: Which Is the Better Dividend Stock?

CVS or Walgreens: Which Is the Better Dividend Stock?

While the two companies seem very similar on the surface, CVS and Walgreens are different stocks for different types of investors.

Stocks Get Chilled: Cramer's 'Mad Money' Recap (Tuesday 3/19/19)

Stocks Get Chilled: Cramer's 'Mad Money' Recap (Tuesday 3/19/19)

Jim Cramer says there's a lot to like about this market, but he says we can't ignore that it's prone to trade-related woes.

Jim Cramer: The Ultimate Case for the Leap of Taste Not Faith

Jim Cramer: The Ultimate Case for the Leap of Taste Not Faith

I think sometimes the best way to parse the temperament is to go over the most obviously 'wrong' moves and address why they might not be wrong at all.

CVS Health Fights Rise In E-Cigarette Use Among Young Adults With More Than $1 Million In New Giving To Advance Tobacco-Free Policies On College Campuses

CVS Health Fights Rise In E-Cigarette Use Among Young Adults With More Than $1 Million In New Giving To Advance Tobacco-Free Policies On College Campuses

82 colleges and universities receive grants from CVS Health Foundation, American Cancer Society and Truth Initiative to help deliver a tobacco-free generation

EQUITY ALERT: Rosen Law Firm Reminds CVS Health Corporation Investors With Over $200K In Losses Of Important Deadline In Securities Class Action Lawsuit - CVS

EQUITY ALERT: Rosen Law Firm Reminds CVS Health Corporation Investors With Over $200K In Losses Of Important Deadline In Securities Class Action Lawsuit - CVS

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of CVS Health Corporation (NYSE: CVS) from May 21, 2015 through February 20, 2019, inclusive (the "Class Period").

Weekly Roundup

Strong earnings boost shares in a rebound week for stocks.

Thank You for Joining Our Members-Only Call on Thursday

A full replay of the call will be available shortly and an edited transcript of the call will be posted in the coming days.

CVS Health

We think shares of CVS deserve to trade at a higher multiple.

Why Investors Should Be Wary of Multiple Expansion: Jim Cramer

Why Investors Should Be Wary of Multiple Expansion: Jim Cramer

Jim Cramer breaks down why investors should be careful about paying more for the same earnings estimate.

Video: Jim's Daily Rundown for Wednesday

Jim discusses Bernstein's initiation of CVS with an Outperform rating, Apple's March 25th event but why they need to focus on healthcare, and more!

CVS Rises Sharply on Bullish Initiation at Bernstein

CVS Rises Sharply on Bullish Initiation at Bernstein

Bernstein initiates coverage of CVS with an outperform rating.

Boeing and CVS: Two Sagas Worth Tracking, But Just One Worth Playing Right Now

Boeing and CVS: Two Sagas Worth Tracking, But Just One Worth Playing Right Now

With all the unknowns surrounding Boeing it's way too early to take a position in the aircraft maker; the same is not true with CVS.

Markets, Trade Deal, Cyber Attacks, My ZTO Play: Market Recon

Markets, Trade Deal, Cyber Attacks, My ZTO Play: Market Recon

National security is job one. Cutting a nice deal with China that benefits both sides must come second.

Jim Cramer: I'm Not Buying This Tech Multiple Expansion

Jim Cramer: I'm Not Buying This Tech Multiple Expansion

This is hope, not fact -- don't pay more for the same old thing.

UnitedHealth Group's Program Shows Why It Is an Industry Leader

We view the commitment to price reductions to be a crucial one that will allow UNH to differentiate itself as the fight for lower healthcare costs heats up.

Video: Jim's Daily Rundown for Tuesday

Jim discusses his view of yesterday's Apple upgrade, transparency around hospital bills, the insider buy activity at CVS, and answers club member questions!

Insider Buying Activity at CVS Health Is a Good Sign

We've seen the value at these levels, insiders are seeing it, and rest of the market should begin to see it too.

Healthy Gains Ahead for Beaten-Down CVS

Healthy Gains Ahead for Beaten-Down CVS

The market's reaction to the pharmacy giant's acquisition of Aetna is providing a rare opportunity to buy a quality company at a value price.

Updates on 4 Portfolio Names (Plus a Video)

When markets move higher, it is no time to be complacent, rather it is a perfect time to check in on the portfolio.

Game Plan After a Disastrous Week: Cramer's 'Mad Money' Recap (Friday 3/8/19)

Game Plan After a Disastrous Week: Cramer's 'Mad Money' Recap (Friday 3/8/19)

Friday's bad employment number could have been a lot worse.

TheStreet Quant Rating: C (Hold)